Targeting Peptides

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Name CAS MF MW Single-letter sequence Three-letter sequence Number of AA Type Inquiry
CTT C52H73N13O14S2 1168.34 H2N-CTTHWGFTLC-OH H2N-Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys-OH 10 MMP-9–targeting peptide
H2009.1 C90H157N31O30 2153.4 H2N-RGDLATLRQLAQEDGVVGVR-OH H2N-Arg-Gly-Asp-Leu-Ala-Thr-Leu-Arg-Gln-Leu-Ala-Gln-Glu-Asp-Gly-Val-Val-Gly-Val-Arg-OH 20 αvβ6 integrin–targeting peptide
EHGAMEI C32H51N9O12S1 785.87 H2N-EHGAMEI-OH H2N-Glu-His-Gly-Ala-Met-Glu-Ile-OH 7 EGFR-targeting peptide
p160 C74H105N17O17S1 1536.79 H2N-VPWMEPAYQRFL-OH H2N-Val-Pro-Trp-Met-Glu-Pro-Ala-Tyr-Gln-Arg-Phe-Leu-OH 12 Keratin-1–targeting peptide
GTI C12H23N3O5 289.33 H2N-GTI-OH H2N-Gly-Thr-Ile-OH 3 Prostate-specific membrane antigen–targeting peptide
P1 C76H97N17O16 1504.69 H2N–HLWGWLYAPSFQ–OH H2N–His–Leu–Trp–Gly–Trp–Leu–Tyr–Ala–Pro–Ser–Phe–Gln–OH 12 Galectin-1–targeting peptide
CPGPEGAGC C30H45N9O12S2 787.86 H2N-CPGPEGAGC-OH H2N-Cys-Pro-Gly-Pro-Glu-Gly-Ala-Gly-Cys-OH 9 Aminopeptidase P–targeting peptide
YCDGFYACYMDV C65H85N13O19S3 1448.64 H2N-YCDGFYACYMDV-NH2 H2N-Tyr-Cys-Asp-Gly-Phe-Tyr-Ala-Cys-Tyr-Met-Asp-Val-NH2 12 HER-2–targeting peptide
HAIYPRH C41H60N14O9 893 H2N-HAIYPRH-OH H2N-His-Ala-Ile-Tyr-Pro-Arg-His-OH 7 TfR-targeting peptide
HTMYYHHYQHHL C77H99N23O18S1 1666.82 H2N-HTMYYHHYQHHL-OH H2N-His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His-His-Leu-OH 12 VEGFR-targeting peptide
IL4RPep-1 C44H82N20O13S2 1163.38 H2N-CRKRLDRNC-OH H2N-Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-OH 9 IL-4R–targeting peptide
E5 C113H181N39O31S1 2613.95 H2N-GGRSFFLLRRIQGCRFRNTVDD-OH H2N-Gly-Gly-Arg-Ser-Phe-Phe-Leu-Leu-Arg-Arg-Ile-Gln-Gly-Cys-Arg-Phe-Arg-Asn-Thr-Val-Asp-Asp-OH 22 CXCR4-targeting peptide
MDDRWPLEYTDDTYEIPW C107H145N23O35S1 2345.49 H2N-MDDRWPLEYTDDTYEIPW-OH H2N-Met-Asp-Asp-Arg-Trp-Pro-Leu-Glu-Tyr-Thr-Asp-Asp-Thr-Tyr-Glu-Ile-Pro-Trp-OH 18 B16 melanoma–targeting peptide
WMW10 C60H88N16O16S1 1321.5 H2N-WMWVTNLRTD-OH H2N-Trp-Met-Trp-Val-Thr-Asn-Leu-Arg-Thr-Asp-OH 10 DLC1 protein–targeting peptide
v6 C27H36N8O10 632.62 H2N-NEWQG-OH H2N-Asn-Glu-Trp-Gln-Gly-OH 5 CD44v6 receptor–targeting peptide
SKPPGTSS C31H53N9O13 759.81 H2N-SKPPGTSS-OH H2N-Ser-Lys-Pro-Pro-Gly-Thr-Ser-Ser-OH 8 Stem cell–targeting peptide;
P7 C68H99N19O18 1470.63 H2N–YSWHIDIVAPRN–OH H2N–Tyr–Ser–Trp–His–Ile–Asp–Ile–Val–Ala–Pro–Arg–Asn–OH 12 Galectin-1–targeting peptide
FHT C63H93N19O18 1404.53 H2N-FHTPSQNSAFRL-OH H2N-Phe-His-Thr-Pro-Ser-Gln-Asn-Ser-Ala-Phe-Arg-Leu-OH 12 Circulating tumor homing cell–targeting peptide
Pep-20 C74H93N21O18 1564.66 H2N-AWSATWSNYWRH-OH H2N-Ala-Trp-Ser-Ala-Thr-Trp-Ser-Asn-Tyr-Trp-Arg-His-OH 12 CD47-targeting peptide
B6 C45H80N18O11S1 1081.3 H2N-CGHKAKGPRK-OH H2N-Cys-Gly-His-Lys-Ala-Lys-Gly-Pro-Arg-Lys-OH 10 Transferrin receptor–targeting peptide